|
FOCUS ON MANUFACTURING CONTROLS |
|
|
|
By Arnaud Deladeriere, Ph.D., Cell&Gene Consulting Inc. | Problems emerge when development, manufacturing, and clinical priorities fail to converge in cell and gene therapy development. | |
|
|
|
|
|
|
|
|
| Quality By Design In The Pharmaceutical Industry | White Paper | Siemens | Real-time release and digital quality management, powered by PAT, are driving efficiency and compliance, reshaping how manufacturers achieve speed, consistency, and competitive advantage. |
|
|
| Digital Innovation And Sustainability Are Redefining Biomanufacturing | White Paper | By Dr. Harald Bradl and Dr. Fabian Vogt, Boehringer Ingelheim Biopharmaceuticals GmbH | Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production. |
|
|
MANUFACTURING CONTROLS SOLUTIONS |
|
|
|
|
|
|
FOCUS ON FACILITIES DESIGN |
|
|
|
|
|
|
|
|
FACILITIES DESIGN SOLUTIONS |
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|